3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Urinary Bladder Neoplasms
2
Sleep Wake Disorders
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Tobacco Use Disorder
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sleep Initiation and Maintenance Disorders
1
Sezary Syndrome
1
Prostate Adenocarcinoma
1
Prostate
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pain
1
Ovarian Neoplasms
1
Interventions
Carboplatin
25
Bevacizumab
18
Paclitaxel
17
Pemetrexed
16
Erlotinib Hydrochloride
14
Radiotherapy
12
Docetaxel
9
Gemcitabine
7
Cisplatin
6
ceritinib
5
Taxes
5
Cetuximab
5
pembrolizumab
3
pegfilgrastim
3
capmatinib
3
Surgical Procedures, Operative
3
Radiosurgery
3
Metformin
3
Gefitinib
3
Cyclophosphamide
3
Thalidomide
2
Sorafenib
2
Radiotherapy, Conformal
2
Nivolumab
2
Immunoglobulin G
2
Filgrastim
2
Disulfides
2
Albumin-Bound Paclitaxel
2
5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide
2
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma of Lung
×
Early Intervention, Educational
×
Clear all
No trials found.